Clinical trials
Thrombosis clinical trials
Below are recruiting thrombosis clinical trials, each written for real people, not researchers. We’re tracking 180 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04660747Recruiting
Anticoagulant medication choices for cerebral venous thrombosis
This study looks at people with cerebral venous thrombosis who were treated with blood thinners taken by mouth (or started within the first 30 days). It uses observational data to understand how these treatments are used and what outcomes may follow.
Amsterdam, North HollandAges 18 years+ - NCT04694248Recruiting
Blood thinner plus antiplatelet after iliac vein stent
This trial looks at whether taking a blood thinner and an additional clot-prevention medicine (antiplatelet) after iliac vein stenting can improve treatment of certain deep vein clots. It may help prevent the clot from coming back or spreading, but it also increases bleeding risk, so careful eligibility screening is important.
Hangzhou, ZhejiangAges 18 years+ - NCT04862468RecruitingPhase 2
Dexamethasone after clot removal to calm leg swelling
This Phase 2 study tests whether a steroid medicine called dexamethasone can reduce inflammation after a clot (DVT) is removed in the thigh/behind-knee veins. If it works, it may help improve recovery and reduce ongoing leg problems after the procedure.
Orange, CaliforniaAges 18–89 - NCT04917328Recruiting
Ultrasound test for less-likely deep vein blood clots
This study looks at whether a certain ultrasound method can safely check for deep vein thrombosis (a blood clot in the leg) when the clot seems less likely. It may help doctors decide faster and avoid unnecessary testing in some people.
StrasbourgAges 18 years+ - NCT05112705Recruiting
Finding deep vein clots early in ICU patients
This study focuses on diagnosing deep-vein thrombosis (DVT, blood clots in the leg) early in people who are very ill in the ICU. It aims to test an approach to better detect clots sooner, which could help prevent complications.
Riyadh, Riyadh RegionAges 18 years+ - NCT05244629Recruiting
Compare two stents for chronic artery-related gut pain
This trial tests whether an uncovered stent or a covered stent works better for treating chronic mesenteric ischemia (reduced blood flow to the intestines from artery narrowing). It’s meant for adults with symptoms and scans showing significant narrowing in a specific gut artery.
København ØAges 18 years+ - NCT05255003RecruitingPhase 4
Anticoagulation options for low platelets with cancer blood clots
This trial studies how best to prevent and treat dangerous blood clots in people with cancer who also have very low platelets. It may help guide safer blood-thinner treatment when bleeding risk is high.
Edmonton, AlbertaAges 18 years+ - NCT05286710Recruiting
Thrombectomy treatment for new blood clots in the leg
This trial studies a procedure to remove an acute deep vein blood clot in the leg. It may help restore blood flow faster than standard treatment for certain clot locations.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06124768Recruiting
Comparing two blood clot removal methods for leg clots
This trial compares two ways of doing a mechanical blood clot removal procedure for people with a new deep vein thrombosis (a blood clot in a deep vein, often in the leg). The goal is to see which method works better.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT06232551Recruiting
Hospital alert to prescribe rivaroxaban to prevent blood clots
This trial tests whether alerting your hospital doctor to prescribe a blood thinner called rivaroxaban (Xarelto) at discharge can help prevent dangerous blood clots in your legs or lungs. It is for patients who are at higher risk for clots but have a low bleeding risk.
Murray, UtahAges 18–110 - NCT06284343Recruiting
Gynecologic Cancer and Blood Clot Risk Study
This study looks at the risk of blood clots in women with gynecologic cancers who are starting a new line of cancer treatment. It aims to help doctors better predict and prevent blood clots in patients like you.
RomeAges 18 years+ - NCT06288906Recruiting
Mechanical Clot Removal for Deep Vein Thrombosis
This trial tests a mechanical device that removes blood clots from deep veins in the pelvis or leg. It may be an option if you have a large clot and are at low risk for bleeding.
Milan, ItalyAges 18 years+ - NCT06386107Recruiting
Bleeding risk in people with cancer and blood clots on blood thinners
This study looks at how well blood thinners work in people with cancer and a recent blood clot. It measures the risk of bleeding by checking certain blood clotting factors.
Clermont-FerrandAges 18 years+ - NCT06389422RecruitingPhase 2
Radiation plus Keytruda for liver cancer with vein clots
This trial tests a combination of moderate-dose radiation therapy and the immunotherapy drug pembrolizumab (Keytruda) for liver cancer that has spread into the main veins of the liver. It aims to see if this combination can shrink tumors and improve survival.
Beijing, Beijing MunicipalityAges 18–90 - NCT06434207Recruiting
Heart defect study in newborns to understand blood clots
This study looks at tiny particles from cells in newborns with heart defects to understand blood clot risks. It aims to find ways to prevent clots after heart surgery.
Boston, MassachusettsAges 1 day–1 week - NCT06531122RecruitingPhase 3
Comparing two blood thinners for cerebral venous thrombosis
This trial compares two blood thinners, Rivaroxaban and Apixaban, to see which works better for people with a blood clot in a brain vein. It may help find the safest and most effective treatment for this condition.
Kafr ash ShaykhAges 18–75 - NCT06551402RecruitingPhase 3
Dabigatran vs rivaroxaban for cerebral venous thrombosis
This study compares two blood thinners (dabigatran and rivaroxaban) to see which works better for treating a blood clot in the brain's veins. You may be eligible if you have a new diagnosis of this type of stroke and can start treatment within 14 days.
Kafr ash ShaykhAges 18–75 - NCT06551415RecruitingPhase 3
Comparing two blood thinners for brain vein clots
This trial compares two blood thinners (dabigatran and apixaban) to see which works better for treating a blood clot in the brain's veins. It might help you if you have a new diagnosis of this type of clot and can take oral blood thinners.
Kafr ash ShaykhAges 18–75 - NCT06581965RecruitingPhase 4
Personalized blood clot prevention for hip or knee replacement
This trial compares a personalized approach to preventing blood clots after hip or knee replacement surgery with the standard one-size-fits-all method. The goal is to see if tailoring prevention to each patient works better and is safer.
Apeldoorn, GelderlandAges 18 years+ - NCT06585228Recruiting
Heart CT vs ultrasound to find clots after stroke
This study compares two ways to look for blood clots in the heart after a stroke: a heart CT scan and an ultrasound done through the food pipe. It aims to see if the CT scan can spot clots just as well as the more invasive ultrasound.
Amsterdam, North HollandAges 18 years+ - NCT06603870RecruitingPhase 4
Preventing blood clots in cancer patients with catheter-related clots
This study tests whether a lower dose of the blood thinner apixaban (Eliquis) can safely prevent another blood clot in people with cancer who have a catheter-related clot in their upper arm or neck. It aims to find a balance between preventing clots and reducing bleeding risk.
Ottawa, OntarioAges 18 years+ - NCT06650826Recruiting
Antibodies and blood clots in young adults
This study looks for certain antibodies in the blood of people aged 18 to 60 who have had a blood clot without a clear cause, or soon after an infection or vaccine, or who have had clots return despite treatment. It aims to understand why these clots happen.
BerlinAges 18–60 - NCT06672250Recruiting
Tumor cells and blood clots in veins
This study looks at the link between tumor cells found in the blood and blood clots in the veins. It is for people who have had or will have a procedure to remove a blood clot, whether they have cancer or not.
New Taipei CityAges 18–80 - NCT06729021Recruiting
Predicting leg blood clots after heart or lung surgery
This study tests whether a simple score (Modified Caprini) and a blood test (D-dimer) can help predict and prevent blood clots in the legs after heart or lung surgery. If you are having cardiothoracic surgery and will be in the hospital for a few days, you may be able to join.
BaghdadAges 18 years+
Hear when a new Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for thrombosis?
- Yes. Clin2 currently lists 180 recruiting thrombosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a thrombosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a thrombosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.